HomepageBICO • STO
add
Bico Group
Vorige slotkoers
kr 36,64
Dag-range
kr 35,36 - kr 36,82
Jaar-range
kr 27,16 - kr 56,55
Beurswaarde
2,45 mld. SEK
Gem. volume
110,58K
Koers/winst
-
Dividendrendement
-
Primaire beurs
STO
Marktnieuws
AP News
2 dagen geleden
AI kingpin Nvidia crowned as first public company with a $4 trillion valuation
0,50%
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (SEK) | mrt 2025info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 388,60 mln. | -17,35% |
Bedrijfskosten | 289,00 mln. | -24,80% |
Netto inkomsten | -234,00 mln. | -729,79% |
Netto winstmarge | -60,22 | -903,67% |
Winst per aandeel | — | — |
EBITDA | -13,80 mln. | 36,99% |
Effectief belastingtarief | -1,42% | — |
Balans
Totale activa
Totale passiva
| (SEK) | mrt 2025info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 684,30 mln. | -14,00% |
Totale activa | 4,74 mld. | -19,97% |
Totale passiva | 2,08 mld. | -27,47% |
Totaal aandelenvermogen | 2,66 mld. | — |
Uitstaande aandelen | 70,57 mln. | — |
Koers-boekwaardeverhouding | 0,98 | — |
Rendement op activa | -3,87% | — |
Rendement op kapitaal | -4,47% | — |
Kasstroom
Nettomutatie in liquide middelen
| (SEK) | mrt 2025info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | -234,00 mln. | -729,79% |
Operationele kasstroom | 76,60 mln. | 542,77% |
Kasstroom uit beleggingen | -5,70 mln. | 86,90% |
Kasstroom uit financiering | -299,90 mln. | -1.728,66% |
Nettomutatie in liquide middelen | -237,20 mln. | -263,25% |
Vrije kasstroom | -232,51 mln. | -981,15% |
Over
Bico Group is a Swedish bioconvergence company that designs and supplies technologies and services to enhance biology research. It focuses on commercializing technologies for life science research as well as bioprinting.
Bico Group began by producing bio-inks and bioprinters for culturing different cell types to enable applications like patient-derived implants. Bico Group was the first company to provide a standardized bio-ink product for sale over the internet.
The company has ongoing collaborations with organizations including AstraZeneca, MedImmune, MIT and Takara Bio, and its bioprinters are used for research at Harvard University, Merck, Novartis, the U.S. Army, Toyota, Johnson & Johnson and more. Wikipedia
Opgericht
27 jan 2016
Website
Werknemers
695
